Doxorubicin-induced vascular toxicity--targeting potential pathways may reduce procoagulant activity.

by Irit Ben Aharon, Hadas Bar Joseph, Moran Tzabari, Boris Shenkman, Nahid Farzam, Mattan Levi, Ruth Shalgi, Salomon M Stemmer, Naphtali Savion
Published 2013-01-01